Transsulfuration pathway activation attenuates oxidative stress and ferroptosis in sickle primary erythroblasts and transgenic mice
*Corresponding author for this work
- ,
- ,
- Augusta University,
- ,
- ,
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Abstract
<p>The transsulfuration (TSS) pathway is an alternative source of cysteine for glutathione synthesis. Little of the TSS pathway in antioxidant capacity in sickle cell disease (SCD) is known. Here, we evaluate the effects of TSS pathway activation through cystathionine beta-synthase (CBS) to attenuate reactive oxygen species (ROS) and ferroptosis stresses in SCD. A vital contribution of the TSS pathway in sustaining cysteine levels is detected only under hemin exposure or physiological but not supraphysiological cystine supplement. Mechanistic studies show that hemin suppresses CBS expression to inhibit the TSS pathway and de novo cysteine biosynthesis. By contrast, the expression of CBS is inducible by dimethyl fumarate (DMF) through nuclear factor erythroid 2-related factor 2 (NRF2) activation and CpG islands DNA hydroxymethylation. DMF induces the expression of L-2-hydroxyglutarate dehydrogenase (L2HGDH) to downregulate L-2-hydroxyglutarate (L2HG) and increase global and locus-specific DNA hydroxymethylation levels. This DMF-upregulated DNA hydroxymethylation affects CBS locus chromatin structure modifications and upregulates gene expression. Our results suggest that CBS of the TSS pathway plays an important role in maintaining cysteine levels under restricted cystine availability or excess hemin exposure, and CBS upregulation by DMF increases the cellular glutathione levels to protect against ROS and ferroptosis stress in SCD. (Figure presented.)</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Article number
15Journal (Volume, Issue Number)
Communications Biology (Volume 8, Issue 1)Publication milestones
- Published - 12/2025
Publication status
Published - 12/2025
Publication IDs
- Scopus: 85214240147
- PubMed: 39762627
Publication metrics
Metrics
Fractional count
7
Fractional count
0.70
Fractional count
3
Fractional count
0.30
Fractional count
7
Fractional count
1
PlumX, opens in new tab
Mentions
1
Citation count
21
Captures
12
Funding Details
We thank the pediatric SCD patients and nurses for their contribution to the collection of blood samples. We thank Dr. Peng Gao from the Metabolomics Core Facility at Northwestern University for conducting the LC-MS metabolomic analysis. These studies used the resources of the Augusta University Proteomics and Mass Spectrometry Core at Georgia Cancer Center. This research was supported by the Augusta University Intramural Pilots Project to X.Z. and B.P. (IGPP00055) and National Institute of Diabetes and Digestive and Kidney Diseases grants to X.Z. (R01DK119762 and R01DK139694).
